Foresight Global Investors, Inc.

CIK 0001973323 · PURCHASE, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-11 · Open the SEC source

Foresight Global Investors, Inc. reported 32 positions worth $165.0M as of June 30, 2026 (13F filed August 11, 2026). Largest holding: NVS (14.6%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$165.0M
2026 Q2
Positions
32
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
87.6%
Est. Net Flow (Q)
2026 Q2
10 / 32 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1NVSNOVARTIS AGSH$24.1M14.60%153,693
2AZNASTRAZENECA PLCSH$22.5M13.66%118,844
3HSBCHSBC HLDGS PLCSH$20.3M12.31%213,514
4SONYSONY GROUP CORPSH$14.9M9.00%740,300
5DBDEUTSCHE BK AGSH$14.8M8.97%438,200
6ALCALCON AGSH$11.8M7.15%175,700
7NVONOVO-NORDISK A SSH$11.8M7.13%245,289
8STMSTMICROELECTRONICS N VSH$8.3M5.03%110,722
9RIORIO TINTO PLCSH$8.2M4.98%86,466
10SAPSAP SESH$7.9M4.80%51,414

The free plan shows the top 10 positions. The remaining 22 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Foresight Global Investors, Inc. hold as of Q2 2026?

Foresight Global Investors, Inc. reported 32 positions worth $165.0M in its Q2 2026 13F filing. Largest positions: NVS (14.6%), AZN (13.7%), HSBC (12.3%), SONY (9.0%) and DB (9.0%).

What did Foresight Global Investors, Inc. buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Foresight Global Investors, Inc. sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.